Mark (India) Cosmed Profile
Key Indicators
- Authorised Capital ₹ 9.50 M
- Paid Up Capital ₹ 8.80 M
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.62 Cr
- Revenue Growth 10.09%
- Profit Growth -424.53%
- Ebitda -85.91%
- Net Worth -3.86%
- Total Assets -18.36%
About Mark (India) Cosmed
Mark (India) Cosmed Private Limited (MICPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 September 1994 and has a history of 30 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 M and a paid-up capital of Rs 8.80 M.
The company currently has active open charges totaling ₹13.62 Cr.
Rajkumar Bharadwaj, Anirudh Ashok, and Ashok Nagarajan serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24240MH1994PTC081139
-
Company No.
081139
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 1994
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mark (India) Cosmed?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Nagarajan
|
Director | 15-Sep-1994 | Current |
|
Rajkumar Bharadwaj
|
Additional Director | 06-Oct-2023 | Current |
|
Anirudh Ashok
|
Director | 20-Mar-2014 | Current |
Financial Performance of Mark (India) Cosmed.
Mark (India) Cosmed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.09% increase. The company also saw a substantial fall in profitability, with a 424.53% decrease in profit. The company's net worth dipped by a decrease of 3.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mark (India) Cosmed?
In 2023, Mark (India) Cosmed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹136.20 M
₹0
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 9.01 Cr
- Icici Bank Limited : 3.96 Cr
- Indian Bank : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2020 | Standard Chartered Bank | ₹2.00 M | Open |
| 03 Nov 2016 | Standard Chartered Bank | ₹4.80 Cr | Open |
| 09 Jul 2015 | Standard Chartered Bank | ₹4.01 Cr | Open |
| 22 Oct 2013 | Indian Bank | ₹6.50 M | Open |
| 01 Mar 2012 | Icici Bank Limited | ₹3.96 Cr | Open |
How Many Employees Work at Mark (India) Cosmed?
Mark (India) Cosmed has a workforce of 45 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mark (India) Cosmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark (India) Cosmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
